All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 100 of 206 pages ‹ First < 98 99 100 101 102 > Last ›
HSL7028
Waters R.
New Schizophrenia Drugs No Better Than Older, Cheaper Generics
BLOOMBERG NEWS 2006 Dec 1
http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aJ2HAZHLooSo
HSL7033
Agres T.
THE FUTURE OF THE FDA : As the agency celebrates its 100th anniversary, what do Congress and others have in store?
The Scientist 2006 Dec 1
http://www.the-scientist.com/2006/12/1/46/1/
HSL7157
Selvin M.
Drug firm reps sue for overtime
The LA Times 2006 Dec 1
http://www.latimes.com/business/la-fi-overtime1dec01,1,3436668.story?coll=la-headlines-business&ctrack=1&cset=true
HSL7259
Enserink M.
Drug research: WHO panel weighs radical ideas
Science 1 December 2006: 1373 2006 Dec 1;314:(5804):1373
http://www.sciencemag.org/cgi/content/full/314/5804/1373
HSL8963
Katz MG, Kripalani S, Weiss BD.
Use of pictorial aids in medication instructions: a review of the literature.
Am J Health Syst Pharm 2006 Dec 1;63:(23):2391-7
http://www.ajhp.org/cgi/content/full/63/23/2391
HSL13572
Treat SA
What States Are Doing About Drug Advertising & Marketing And Prescription Data Confidentiality: A Summary Of Recent Advertising & Marketing Legislation
Hartford, Connecticut: National Legislative Association on Prescription Drug Prices 2006 Dec 1
http://www.progressivestates.org/resources/drugmarketing1.pdf
HSL20066
Clark VA
Why the fuss?
Australian Doctor 2006 Dec 123
HSL7018
Netterwald J.
Will the Sun come out Tomorrow?
Drug Discovery & Development Magazine (DDDMag) 2006 Dec
http://www.dddmag.com/ShowPR~PUBCODE~016~ACCT~1600000100~ISSUE~0612~RELTYPE~CVS~PRODCODE~00000000~PRODLETT~U.html
HSL7027
Check E.
The Treasure of Mumbai: To Big Pharma, Indian drugmaker Cipla is a pirate operation. To the developing world, it's a vital medicine chest. And now its cheap pills are coming to a pharmacy near you.
Wired Magazine 2006 Dec
HSL7258
Committee on Communications, American Academy of Pediatrics; Strasburger VC.
Children, adolescents, and advertising.
Pediatrics 2006 Dec;118:(6):2563-9
http://pediatrics.aappublications.org/cgi/content/full/118/6/2563
HSL7360
Montagnier D, Barberger-Gateau P, Jacqmin-Gadda H, Dartigues JF, Rainfray M, Peres K, Lechevallier-Michel N, Fourrier-Reglat A.
Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: results from the personnes agees quid study.
J Am Geriatr Soc 2006 Dec;54:(12):1839-45
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17198488&query_hl=1&itool=pubmed_docsum
HSL7426
Fisher D.
Do the right thing (or Do the market exclusivity thing?)
Anesthesiology 2006 Dec;105:(6):1074-5
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000542-200612000-00003
HSL7438
Durkin S, Wakefield M, Spittal M.
Looking for boomerang effects: a pre-post experimental study of the effects of exposure of youth to television advertising for nicotine replacement therapy and Zyban.
Addict Behav 2006 Dec;31:(12):2158-68
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VC9-4JKHN66-4&_coverDate=12%2F31%2F2006&_alid=525182849&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5949&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=dc607f55005a3dfacdf0e34f5a4bf672
HSL7506
Hanauer SB.
A generic problem.
Nat Clin Pract Gastroenterol Hepatol 2006 Dec;3:(12):649
HSL7511
Gray NS.
Drug discovery through industry-academic partnerships.
Nat Chem Biol 2006 Dec;2:(12):649-53
http://www.nature.com/nchembio/journal/v2/n12/abs/nchembio1206-649.html;jsessionid=B33CC71C3E65C6ECFE4E0B4A0A3176CA
HSL7539
Hampl JS, Bramlett-Solomon S, Wharton CM.
Direct-to-consumer advertising of prescription medications: Do you see what the public sees?
J Am Diet Assoc 2006 Dec;106:(12):1937-40,
http://linkinghub.elsevier.com/retrieve/pii/S0002-8223(06)02295-4
HSL7665
Kessel M, Hall S.
Avoiding premature licensing.
Nat Rev Drug Discov 2006 Dec;5:(12):985-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17201025&dopt=Abstract
HSL7667
Frantz S.
Pipeline problems are increasing the urge to merge.
Nat Rev Drug Discov 2006 Dec;5:(12):977-9
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17201023&dopt=Abstract
HSL7772
Mandel LL, Bialous SA, Glantz SA.
Avoiding 'truth': tobacco industry promotion of life skills training
J Adolesc Health 2006 Dec;39:(6):868-79
http://linkinghub.elsevier.com/retrieve/pii/S1054-139X(06)00252-7
HSL8025
Edwards RG.
Open conflict on the handling of the Merck drug Vioxx by editorial giants.
Reprod Biomed Online 2006 Dec;13:(6):905
http://www.ingentaconnect.com/content/repro/rebi/2006/00000013/00000006/art00020?token=004a1147c644a467b4d616d3f4e4b34496e5865462440344257205f5d58763c5f535b23acc
HSL8032
Kennedy SP, Bormann BJ.
Effective partnering of academic and physician scientists with the pharmaceutical drug development industry.
Exp Biol Med (Maywood) 2006 Dec;231:(11):1690-4
http://www.ebmonline.org/cgi/content/full/231/11/1690
HSL8033
Clackson T.
Translational research in academia and industry.
Exp Biol Med (Maywood) 2006 Dec;231:(11):1685-9
http://www.ebmonline.org/cgi/content/full/231/11/1685
HSL8052
Chapman K, Nicholas P, Banovic D, Supramaniam R.
The extent and nature of food promotion directed to children in Australian supermarkets.
Health Promot Int 2006 Dec;21:(4):331-9
http://heapro.oxfordjournals.org/cgi/content/full/21/4/331
HSL8250
Stagnitti, MN
The top five therapeutic classes of outpatient prescription drugs ranked by total expense for adults age 18 and older in the US civilian noninstitutionalized population, 2004. Statistical Brief #154.
Rockville, MD: Agency for Healthcare Research and Quality 2006 Dec
http://www.meps.ahrq.gov/mepsweb/data_files/publications/st154/stat154.pdf.
HSL8251
Stagnitti, MN
The top five therapeutic classes of outpatient prescription drugs ranked by total expense for the Medicare population age 65 and older in the US civilian noninstitutionalized population, 2004. Statistical Brief #153.
Rockville, MD: Agency for Healthcare Research and Quality 2006 Dec
http://www.meps.ahrq.gov/mepsweb/data_files/publications/st153/stat153.pdf
HSL8264
Pawaskar MD, Sansgiry SS.
Over-the-counter medication labels: Problems and needs of the elderly population.
J Am Geriatr Soc 2006 Dec;54:(12):1955-6
http://www.blackwell-synergy.com/doi/full/10.1111/j.1532-5415.2006.00958.x
HSL8265
Hundley RF.
Physicians and industry: regaining independence.
J Ark Med Soc 2006 Dec;103:(6):124-5
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17190407&dopt=Abstract
HSL8269
Haga SB, Thummel KE, Burke W.
Adding pharmacogenetics information to drug labels: lessons learned.
Pharmacogenet Genomics 2006 Dec;16:(12):847-54
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=01213011-200612000-00001
HSL8419
Jolley G, Baum F, Bentley M, Hurley C, Johnson A, Lawless A, MacDougall C.
Pharmaceutical ads in ANZJPH.
Aust N Z J Public Health 2006 Dec;30:(6):580
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17209279&dopt=Abstract
HSL8426
Partin B.
Preventing medication errors: an IOM Report.
Nurse Pract 2006 Dec;31:(12):8
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00006205-200612000-00002
HSL8428
Franz CE, Epstein R, Miller KN, Brown A, Song J, Feldman M, Franks P, Kelly-Reif S, Kravitz RL.
Caught in the act? Prevalence, predictors, and consequences of physician detection of unannounced standardized patients
Health Serv Res. 2006 Dec;41:(6):2290-302.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17116121&dopt=Abstract
HSL8429
Veldhuijzen DS, van Wijck AJ, Verster JC, Kalkman CJ, Kenemans JL, Olivier B, Volkerts ER.
The impact of chronic pain patients' psychotropic drug knowledge and warning labels on the decision whether to drive a car or not.
Traffic Inj Prev 2006 Dec;7:(4):360-4
http://taylorandfrancis.metapress.com/(lip3x045eeeacfywaero2jqv)/app/home/contribution.asp?referrer=parent&backto=issue,8,14;journal,1,21;linkingpublicationresults,1:300371,1
HSL8509
Suhadev M, Nyamathi AM, Swaminathan S, Venkatesan P, Raja Sakthivel M, Shenbagavalli R, Suresh A, Fahey JL.
A pilot study on willingness to participate in future preventive HIV vaccine trials.
Indian J Med Res 2006 Dec;124:(6):631-40
http://www.icmr.nic.in/ijmr/2006/december/1208.pdf
HSL8513
Ibiassi JP.
[Study on the quality of pharmaceutical advertising in a pharmacy in Congo Brazzaville.]
Med Trop (Mars) 2006 Dec;66:(6):581-2
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Ibiassi+JP%22%5BAuthor%5D
HSL8520
Lexchin J.
A comparison of new drug availability in Canada and the United States and potential therapeutic implications of differences.
Health Policy 2006 Dec;79:(2-3):214-20
http://linkinghub.elsevier.com/retrieve/pii/S0168-8510(06)00003-0
HSL8666
[No authors listed]
Attention to detailing.
Harv Health Lett. 2006 Dec;32:(2):5
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17297728&query_hl=7&itool=pubmed_DocSum
HSL8674
Jain KK.
Challenges of drug discovery for personalized medicine.
Curr Opin Mol Ther 2006 Dec;8:(6):487-92
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17243483&query_hl=1&itool=pubmed_DocSum
HSL8676
[No authors listed].
Pharmaceutical companies and health plans have a shared interest in boosting medication adherence.
Dis Manag Advis 2006 Dec;12:(12):143-4,
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17225632&query_hl=3&itool=pubmed_DocSum
HSL8684
Denelsbeck S.
Engaging employees in health and wellness: the
Am J Manag Care 2006 Dec;12:
http://www.ajmc.com/article.cfm?ID=3248
HSL8686
Fox JL.
The business of developing antibacterials.
Nat Biotechnol 2006 Dec;24:(12):1521-8
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1521.html
HSL8687
Brenner R, Ellis-Grosse EJ, Echols R.
Moving goalposts--regulatory oversight of antibacterial drugs.
Nat Biotechnol 2006 Dec;24:(12):1515-20
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1515b.html
HSL8688
Christoffersen RE.
Antibiotics--an investment worth making?
Nat Biotechnol 2006 Dec;24:(12):1512-4
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1512.html
HSL8689
Fernandes P.
Antibacterial discovery and development--the failure of success?
Nat Biotechnol 2006 Dec;24:(12):1497-503
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1497.html
HSL8690
[No authors listed].
Bring the magic back to the bullets.
Nat Biotechnol 2006 Dec;24:(12):1489
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1489.html
HSL8691
Sheridan C.
European pharma consolidation generates quality spinoffs.
Nat Biotechnol 2006 Dec;24:(12):1458-9
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1458.html
HSL8692
Ransom J.
Niche indications could drive higher valuations.
Nat Biotechnol 2006 Dec;24:(12):1457
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1457.html
HSL8693
Hollmer M.
Biotech takes aim at large anti-estrogen markets.
Nat Biotechnol 2006 Dec;24:(12):1455-6
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1455.html
HSL8694
[No authors listed].
A billion dollar punt.
Nat Biotechnol 2006 Dec;24:(12):1453
http://www.nature.com/nbt/journal/v24/n12/full/nbt1206-1453.html
HSL8695
Lee KK.
Discontinued drugs in 2005: pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs.
Expert Opin Investig Drugs 2006 Dec;15:(12):1497-505
http://www.expertopin.com/doi/full/10.1517/13543784.15.12.1497
HSL8696
Windsor JS, Middleton PM.
Incorrect labelling of naloxone.
Anaesthesia 2006 Dec;61:(12):1230
http://www.blackwell-synergy.com/doi/full/10.1111/j.1365-2044.2006.04890_1.x
HSL8729
Strumeyer C, Lion A.
[The image of the mother in advertising].
Soins Pediatr Pueric 2006 Dec;(233):28-30
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17236380&query_hl=13&itool=pubmed_DocSum
HSL8732
Fuhrlinger S.
[Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
Wien Med Wochenschr 2006 Dec;156:(23-24):612-8
http://www.springerlink.com/content/u114425176447p12/
HSL8738
Dorsey ER, Vitticore P, De Roulet J, Thompson JP, Carrasco M, Johnston SC, Holloway RG, Moses H 3rd.
Financial anatomy of neuroscience research.
Ann Neurol 2006 Dec;60:(6):652-9
http://www3.interscience.wiley.com/cgi-bin/abstract/114031266/ABSTRACT?CRETRY=1&SRETRY=0
HSL8741
Tremaine WJ.
Biologics for inflammatory bowel disease: drug approval and monitoring in the United States.
Gastroenterol Clin North Am 2006 Dec;35:(4):735-41
http://www.gastro.theclinics.com/article/PIIS0889855306000860/fulltext
HSL8744
Stein R.
Arzneimitteldesinformation eher Regel als Ausnahme
Berliner Ärzte 2006 Dec;43:(12):16 - 20
http://www.l-va.city-bizzy.de/berlin/pdf/bae0612_016.pdf
HSL8787
Yvon AM.
Settlements between brand and generic pharmaceutical companies: a reasonable antitrust analysis of reverse payments.
Fordham Law Rev 2006 Dec;75:(3):1883-912
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17312596&query_hl=4&itool=pubmed_DocSum
HSL8791
Hansen LB, Saseen JJ, Westfall JM, Holcomb S, Nuzum DS, Pace WD.
Evaluating sample medications in primary care: a practice-based research network study.
Jt Comm J Qual Patient Saf 2006 Dec;32:(12):688-92
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17220158&query_hl=2&itool=pubmed_DocSum
HSL9006
Maclean A.
Autonomy, consent and persuasion.
Eur J Health Law 2006 Dec;13:(4):321-38
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17302359&query_hl=8&itool=pubmed_DocSum
HSL9017
Perel ML.
Today's professional symbiosis.
Implant Dent 2006 Dec;15:(4):321
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00008505-200612000-00001
HSL9275
Gordon R, McDermott L, Stead M, Angus K.
The effectiveness of social marketing interventions for health improvement: what's the evidence?
Public Health 2006 Dec;120:(12):1133-9
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B73H6-4MBBYYR-1&_user=10&_coverDate=12%2F31%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=9fc1abe201d7de3da374de66209ffbb9
HSL10061
Carneiro AV.
Efficacy claims for new drugs without clinical trial outcome data: problems and pitfalls.
Rev Port Cardiol 2006 Dec;25:(12):1127-42
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17343103&query_hl=20&itool=pubmed_DocSum
HSL10324
La Revue Prescrire.
[Prescribe and advise freely].
Med Trop (Mars). 2006 Dec;66:(6):577-80
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17286025
HSL10335
Videau JY.
[Quality of medicines in least developed countries].
Med Trop (Mars) 2006 Dec;66:(6):533-7
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17286015
HSL10336
Velasquez G.
[Intellectual property rights and right of access to medicines].
Med Trop (Mars) 2006 Dec;66:(6):526-8
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17286013
HSL10780
Gutteridge WE.
TDR collaboration with the pharmaceutical industry.
Trans R Soc Trop Med Hyg 2006 Dec;100:
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B75GP-4K1X5RN-5&_user=10&_coverDate=12%2F31%2F2006&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=e89d9ac46e58e582c525fe7b8fbcbda7
HSL10807
Yang J.
Modern medicine environment and adaptation of Korean trader for medicinal herbs from the late 19th century to the early 20th century
Uisahak. 2006 Dec;15:(2):189-209
HSL10973
Klein D, MacDonald A, Drummond N, Cave A.
A qualitative study to identify factors influencing COXIB prescribed by family physicians for musculoskeletal disorders.
Fam Pract 2006 Dec;23:(6):659-65
http://fampra.oxfordjournals.org/cgi/content/full/23/6/659
HSL11322
Barends DM, Groot DW, van der Steen JC, de Kaste D, Frijlink HW.
Results of a market surveillance study in The Netherlands on break-mark tablets.
2006 Dec;2006:(2):1-7
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17691208&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
HSL11674
Nishtar S.
Pharmaceuticals--strategic considerations in health reforms in Pakistan.
J Pak Med Assoc 2006 Dec;56:(12):
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17595837
HSL12009
Goldberg ME, Davis RM, O'Keefe AM.
The role of tobacco advertising and promotion: themes employed in litigation by tobacco industry witnesses.
Tob Control 2006 Dec;15:
http://tobaccocontrol.bmj.com/cgi/content/abstract/15/suppl_4/iv54
HSL12856
Salas SP, Osorio F M, Vial C P, Rehbein V AM, Salas A C, Beca I JP.
[Conflicts of interest in clinical practice: Ethical analysis of some relationships with the pharmaceutical industry]
Rev Med Chil 2006 Dec;134:(12):1576-82.
http://www.scielo.cl/cgi-bin/fbpe/fbtext?pid=S0034-98872006001200014&lng=en&nrm=iso&tlng=en
HSL18243
Roughead EE.
Enhancing early uptake of drug evidence into primary care.
Expert Rev Pharmacoecon Outcomes Res 2006 Dec;6:(6):661-71
http://www.expert-reviews.com/doi/abs/10.1586/14737167.6.6.661?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=ncbi.nlm.nih.gov
HSL6992
Nainggolan L.
Hard Data Lacking for Most Nutraceuticals
Medscape 2006 Nov 30;
HSL7004
Mitchell E.
Drugs' expiration dates in question
NEWSDAY 2006 Nov 30
HSL7005
Griffith D.
UCD to reject drug gifts: In ethics ruling, the medical center tells doctors to just say no to drug company reps bearing free samples and lunches.
The Sacramento Bee 2006 Nov 30
http://www.sacbee.com/101/story/85056.html
HSL7007
Weiss R.
Most Cancer Patients Unconcerned About Doctors' Ties to Drug Firms: Research Reviewers Also May Often Have Links to Industry
The Washington Post 2006 Nov 30
http://www.washingtonpost.com/wp-dyn/content/article/2006/11/29/AR2006112901387_pf.html
HSL7014
Dow S.
Call to expose link to doctors
The Age 2006 Nov 30
http://www.theage.com.au/news/national/call-to-expose-link-to-doctors/2006/11/29/1164777654871.html
HSL7064
Campbell EG, Weissman JS, Vogeli C, Clarridge BR, Abraham M, Marder JE, Koski G.
Financial relationships between institutional review board members and industry.
N Engl J Med 2006 Nov 30;355:(22):2321-9
http://content.nejm.org/cgi/content/abstract/355/22/2321?ijkey=a42c49355161ddd0e8c4f65c30f7f58bb60dbda6
HSL7156
Cohen F.
GlaxoSmithKline Likely To Cut Salesforce Next
Yahoo Finance 2006 Nov 30
http://biz.yahoo.com/seekingalpha/061130/21528_id.html?.v=1
HSL7158
Langreth R.
Six Pfizer Drugs To Watch
Forbes.com 2006 Nov 30
http://www.forbes.com/2006/11/30/pfizer-drug-pipeline-biz-cz_rl_1130drugs.html?partner=yahootix
HSL7159
Harrison V.
Study may reveal cause of Vioxx side effects
Pharmaceutical Business Review 2006 Nov 30
http://www.pharmaceutical-business-review.com/article_news.asp?guid=F99CA471-BDFE-4A16-8F5F-491693B70504
HSL7166
Allrich T.
Pfizer's Wake Up Call
Yahoo Finance 2006 Nov 30
http://biz.yahoo.com/seekingalpha/061130/21494_id.html?.v=1
HSL7168
Brickates Kennedy V.
Pfizer cuts signal shift in Big Pharma marketing
Market Watch 2006 Nov 30
http://www.marketwatch.com/News/Story/Story.aspx?guid=%7B2AC9B9E8%2DC455%2D4CC5%2D8155%2DE823443D0A6A%7D&source=blq%2Fyhoo&dist=yhoo&siteid=yhoo
HSL7170
Greenberg H.
IMS Health Says Pfizer Cuts Won't Hurt Its Business
Yahoo Finance 2006 Nov 30
http://biz.yahoo.com/seekingalpha/061130/21463_id.html?.v=1
HSL7419
Haug C.
[Taking the drug industry seriously]
Tidsskr Nor Laegeforen. 2006 Nov 30;126:(23):3081
http://www.tidsskriftet.no/pls/lts/pa_lt.visSeksjon?vp_SEKS_ID=1457257
HSL6466
Dow S.
Drug company 'forked out $180 a head for banquet'
Age Newspaper (Melbourne) 2006 Nov 29
http://www.theage.com.au/news/national/drug-company-forked-out-180-a-head-for-banquet/2006/11/28/1164476205090.html
HSL7006
Agovino T.
Drug maker Pfizer cuts 2,200 U.S. sales jobs as part of reorganization
The Associated Press 2006 Nov 29
HSL7008
Hospital boards too closely tied to industry Panels that oversee experiments tainted by conflicts of interest, study finds
The Associated Press 2006 Nov 29
http://www.msnbc.msn.com/id/15954759/
HSL7009
Healthday NEWS.
Ob/Gyn Group Urges Pregnant Women to Shun Paxil
Forbes.com 2006 Nov 29
http://www.forbes.com/forbeslife/health/feeds/hscout/2006/11/29/hscout536339.html
HSL7167
Steyer R.
Panel Backs New Use for Celebrex
The Street.com 2006 Nov 29
http://www.thestreet.com/_yahoo/newsanalysis/pharmaceuticals/10325028.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
HSL7169
Agovino T.
Pfizer Move May Prompt More Job Cuts: Analysts Say Pfizer Decision to Ax 2,200 Jobs May Force Other Companies to Cut Their Own Ranks
Yahoo Finance 2006 Nov 29
http://biz.yahoo.com/ap/061129/pfizer_job_cuts.html?.v=5
HSL7174
Towns S.
Pfizer's Sales Force Cut: Like 'The End of an Arms Race'
Yahoo Finance 2006 Nov 29
http://biz.yahoo.com/seekingalpha/061129/21398_id.html?.v=1
HSL7175
Gerlin A.
Glaxo Leads European Drugmakers Higher on Pfizer Cuts
Bloomberg.com 2006 Nov 29
http://www.bloomberg.com/apps/news?pid=20601202&sid=aNG5T8RunPOs&refer=healthcare
HSL7176
Richwine L.
Drug reviewers question Pfizer pain drug data
Yahoo Finance 2006 Nov 29
http://biz.yahoo.com/rb/061128/pfizer_celebrex.html?.v=2
HSL6465
Madden J.
Drug firms challenge crackdown on gifts
The Australian Newswpaper 2006 Nov 28
http://www.theaustralian.news.com.au/story/0,20867,20832556-2702,00.html
HSL6997
Weber LJ, Bissell MG.
There is no such thing as free pizza.
Clin Leadersh Manag Rev 2006 Nov 28;20:(6):E8
HSL7171
Herper M.
Pfizer Cuts Could Change Drug Business
Forbes.com 2006 Nov 28
http://www.forbes.com/2006/11/28/pharmacuticals-pfizer-merck-biz-sci_cx_mh_1128pfizer.html?partner=yahootix
HSL7172
Steyer R.
Pfizer Slashes Sales Force
Forbes.com 2006 Nov 28
http://www.thestreet.com/_yahoo/newsanalysis/pharmaceuticals/10324738.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
HSL7173
Novartis submits two new drugs to FDA: Swiss drug giant Novartis to hire 1,000 additional U.S. sales reps , says CEO.
CNN Money.com 2006 Nov 28
http://money.cnn.com/2006/11/28/news/companies/novartis.reut/index.htm?source=yahoo_quote
HSL7177
Smith A.
Pfizer's new inhalable insulin slow to catch on: Experts thought No. 1 drugmaker had surefire winner with Exubera, but jury is still out.
CNN Money 2006 Nov 28
http://money.cnn.com/2006/11/28/news/companies/exubera/index.htm?source=yahoo_quote
Page 100 of 206 pages ‹ First < 98 99 100 101 102 > Last ›
